Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
1177:HKHong Kong

Sino Biopharmaceutical Ltd

COMPANY INFO
7.65HKD
-0.17-2.17%
Market Open
As of 10:45 PM EDT 05/20/2019 EDT
Open
7.74
Prev Close
7.82
Volume
15,451,000
Market Cap
98.441B
Day Range
7.607.80
52 Week Range
4.5313.93
1D1M1Y5Y
View Full Chart
Market Open
As of 10:45 PM EDT 05/20/2019 EDT
1D1M1Y5Y
View Full Chart
markets
Don’t See a Lot of Risk Premium Across Many Asset Classes, Says Conning’s Yeo
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio9.47
Bloomberg (BEst) P/E Ratio26.1773
Bloomberg (BEst) PEG Ratio2.3383
Shares Outstanding12.59B
Price to Book Ratio2.8888
Price to Sales Ratio4.1883
1 Year Return-37.10%
30 Day Avg Volume53,714,300
EPS0.73
Bloomberg (BEst) EPS Curr Yr0.2500
Dividend0.96%
Last Dividend Reported0.02
Earnings Announcement for Period Ending Q2/2019:05/21/2019

Compare
1-Day Performance

-3%0
-3%0
Equity
1177:HK
-2.17%
Sponsored By

About Sino Biopharmaceutical Ltd

Sino Biopharmaceutical Limited, through its subsidiaries, researches, develops, produces, and sells biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis.
Address
Room 4109, Office Tower Convention Plaza 1, Harbour Ro Wanchai Hong Kong Hong Kong (SAR)
Phone
852-2802-9886
Website
www.sino-biopharm.com

Income Statement

Quarterly
Annual
;
Q4 2018 (Billions HKD)
  • Revenue
    6.0
  • Net Income
    8.0
  • Profit Margin
    132.70%

Balance Sheet

Quarterly
Annual
;
Q4 2018 (Billions HKD)
  • Total Assets
    57.0
  • Total Liabilities
    14.0
  • Debt to Assets
    6.86%

Cash Flow

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q2 2019 (Millions HKD)
  • Operating
    --
  • Investing
    --
  • Financing
    --